Advanced HIV disease: A review of diagnostic and prophylactic strategies
Article Swipe
Alice Lehman
,
Jayne Ellis
,
Elizabeth Nalintya
,
Nathan C. Bahr
,
Angela Loyse
,
Radha Rajasingham
·
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1111/hiv.13487
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1111/hiv.13487
Background Despite expanded access to antiretroviral therapy (ART) and the rollout of the World Health Organization's (WHO) ‘test‐and‐treat’ strategy, the proportion of people with HIV (PWH) presenting with advanced HIV disease (AHD) remains unchanged at approximately 30%. Fifty percent of persons with AHD report prior engagement to care. ART failure and insufficient retention in HIV care are major causes of AHD. People living with AHD are at high risk for opportunistic infections and death. In 2017, the WHO published guidelines for the management of AHD that included a comprehensive package of care for screening and prophylaxis of major opportunistic infections (OIs). In the interim, ART regimens have evolved: integrase inhibitors are first‐line therapy globally, and the diagnostic landscape is evolving. The objective of this review is to highlight novel point‐of‐care (POC) diagnostics and treatment strategies that can facilitate OI screening and prophylaxis for persons with AHD. Methods We reviewed the WHO guidelines for recommendations for persons with AHD. We summarized the scientific literature on current and emerging diagnostics, along with emerging treatment strategies for persons with AHD. We also highlight the key research and implementation gaps together with potential solutions. Results While POC CD4 testing is being rolled out in order to identify persons with AHD, this alone is insufficient; implementation of the Visitect CD4 platform has been challenging given operational and test interpretation issues. Numerous non‐sputum POC TB diagnostics are being evaluated, many with limited sensitivity. Though imperfect, these tests are designed to provide rapid results (within hours) and are relatively affordable for resource‐poor settings. While novel POC diagnostics are being developed for cryptococcal infection, histoplasmosis and talaromycosis, implementation science studies are urgently needed to understand the clinical benefit of these tests in the routine care. Conclusions Despite progress with HIV treatment and prevention, a persistent 20%–30% of PWH present to care with AHD. Unfortunately, these persons with AHD continue to carry the burden of HIV‐related morbidity and mortality. Investment in the development of additional POC or near‐bedside CD4 platforms is urgently needed. Implementation of POC diagnostics theoretically could improve HIV retention in care and thereby reduce mortality by overcoming delays in laboratory testing and providing patients and healthcare workers with timely same‐day results. However, in real‐world scenarios, people with AHD have multiple comorbidities and imperfect follow‐up. Pragmatic clinical trials are needed to understand whether these POC diagnostics can facilitate timely diagnosis and treatment, thereby improving clinical outcomes such as HIV retention in care.
Related Topics
Concepts
Metadata
- Type
- review
- Language
- en
- Landing Page
- https://doi.org/10.1111/hiv.13487
- https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/hiv.13487
- OA Status
- hybrid
- Cited By
- 24
- References
- 93
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4364374455
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4364374455Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1111/hiv.13487Digital Object Identifier
- Title
-
Advanced
HIV disease: A review of diagnostic and prophylactic strategiesWork title - Type
-
reviewOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2023Year of publication
- Publication date
-
2023-04-11Full publication date if available
- Authors
-
Alice Lehman, Jayne Ellis, Elizabeth Nalintya, Nathan C. Bahr, Angela Loyse, Radha RajasinghamList of authors in order
- Landing page
-
https://doi.org/10.1111/hiv.13487Publisher landing page
- PDF URL
-
https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/hiv.13487Direct link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
hybridOpen access status per OpenAlex
- OA URL
-
https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/hiv.13487Direct OA link when available
- Concepts
-
Medicine, Human immunodeficiency virus (HIV), Disease, Intensive care medicine, Virology, Internal medicineTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
24Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 16, 2024: 6, 2023: 2Per-year citation counts (last 5 years)
- References (count)
-
93Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4364374455 |
|---|---|
| doi | https://doi.org/10.1111/hiv.13487 |
| ids.doi | https://doi.org/10.1111/hiv.13487 |
| ids.openalex | https://openalex.org/W4364374455 |
| fwci | 8.47330551 |
| type | review |
| title | Advanced |
| biblio.issue | 8 |
| biblio.volume | 24 |
| biblio.last_page | 876 |
| biblio.first_page | 859 |
| grants[0].funder | https://openalex.org/F4320337355 |
| grants[0].award_id | |
| grants[0].funder_display_name | National Institute of Allergy and Infectious Diseases |
| topics[0].id | https://openalex.org/T12369 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9998000264167786 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2713 |
| topics[0].subfield.display_name | Epidemiology |
| topics[0].display_name | Pneumocystis jirovecii pneumonia detection and treatment |
| topics[1].id | https://openalex.org/T10981 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9993000030517578 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2713 |
| topics[1].subfield.display_name | Epidemiology |
| topics[1].display_name | Cytomegalovirus and herpesvirus research |
| topics[2].id | https://openalex.org/T13761 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9991000294685364 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2739 |
| topics[2].subfield.display_name | Public Health, Environmental and Occupational Health |
| topics[2].display_name | HIV/AIDS oral health manifestations |
| funders[0].id | https://openalex.org/F4320337355 |
| funders[0].ror | https://ror.org/043z4tv69 |
| funders[0].display_name | National Institute of Allergy and Infectious Diseases |
| is_xpac | False |
| apc_list.value | 3760 |
| apc_list.currency | USD |
| apc_list.value_usd | 3760 |
| apc_paid.value | 3760 |
| apc_paid.currency | USD |
| apc_paid.value_usd | 3760 |
| concepts[0].id | https://openalex.org/C71924100 |
| concepts[0].level | 0 |
| concepts[0].score | 0.9397917985916138 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[0].display_name | Medicine |
| concepts[1].id | https://openalex.org/C3013748606 |
| concepts[1].level | 2 |
| concepts[1].score | 0.5878633856773376 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q15787 |
| concepts[1].display_name | Human immunodeficiency virus (HIV) |
| concepts[2].id | https://openalex.org/C2779134260 |
| concepts[2].level | 2 |
| concepts[2].score | 0.5376135110855103 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q12136 |
| concepts[2].display_name | Disease |
| concepts[3].id | https://openalex.org/C177713679 |
| concepts[3].level | 1 |
| concepts[3].score | 0.45087265968322754 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q679690 |
| concepts[3].display_name | Intensive care medicine |
| concepts[4].id | https://openalex.org/C159047783 |
| concepts[4].level | 1 |
| concepts[4].score | 0.23403015732765198 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q7215 |
| concepts[4].display_name | Virology |
| concepts[5].id | https://openalex.org/C126322002 |
| concepts[5].level | 1 |
| concepts[5].score | 0.21352064609527588 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[5].display_name | Internal medicine |
| keywords[0].id | https://openalex.org/keywords/medicine |
| keywords[0].score | 0.9397917985916138 |
| keywords[0].display_name | Medicine |
| keywords[1].id | https://openalex.org/keywords/human-immunodeficiency-virus |
| keywords[1].score | 0.5878633856773376 |
| keywords[1].display_name | Human immunodeficiency virus (HIV) |
| keywords[2].id | https://openalex.org/keywords/disease |
| keywords[2].score | 0.5376135110855103 |
| keywords[2].display_name | Disease |
| keywords[3].id | https://openalex.org/keywords/intensive-care-medicine |
| keywords[3].score | 0.45087265968322754 |
| keywords[3].display_name | Intensive care medicine |
| keywords[4].id | https://openalex.org/keywords/virology |
| keywords[4].score | 0.23403015732765198 |
| keywords[4].display_name | Virology |
| keywords[5].id | https://openalex.org/keywords/internal-medicine |
| keywords[5].score | 0.21352064609527588 |
| keywords[5].display_name | Internal medicine |
| language | en |
| locations[0].id | doi:10.1111/hiv.13487 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S56736983 |
| locations[0].source.issn | 1464-2662, 1468-1293 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | 1464-2662 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | HIV Medicine |
| locations[0].source.host_organization | https://openalex.org/P4310320595 |
| locations[0].source.host_organization_name | Wiley |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320595 |
| locations[0].license | cc-by-nc-nd |
| locations[0].pdf_url | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/hiv.13487 |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by-nc-nd |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | HIV Medicine |
| locations[0].landing_page_url | https://doi.org/10.1111/hiv.13487 |
| locations[1].id | pmh:oai:openaccess.sgul.ac.uk:115407 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306400552 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | St George's Online Research Archive (St George's University of London) |
| locations[1].source.host_organization | https://openalex.org/I165862685 |
| locations[1].source.host_organization_name | St George's, University of London |
| locations[1].source.host_organization_lineage | https://openalex.org/I165862685 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | acceptedVersion |
| locations[1].raw_type | Article |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | False |
| locations[1].raw_source_name | |
| locations[1].landing_page_url | |
| locations[2].id | pmh:oai:researchonline.lshtm.ac.uk:4669629 |
| locations[2].is_oa | False |
| locations[2].source.id | https://openalex.org/S4306402527 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | LSHTM Research Online (London School of Hygiene and Tropical Medicine) |
| locations[2].source.host_organization | https://openalex.org/I4210089966 |
| locations[2].source.host_organization_name | London School of Hygiene & Tropical Medicine |
| locations[2].source.host_organization_lineage | https://openalex.org/I4210089966 |
| locations[2].license | |
| locations[2].pdf_url | |
| locations[2].version | acceptedVersion |
| locations[2].raw_type | Article |
| locations[2].license_id | |
| locations[2].is_accepted | True |
| locations[2].is_published | False |
| locations[2].raw_source_name | |
| locations[2].landing_page_url | https://researchonline.lshtm.ac.uk/view/creators/lsh334887.html>; |
| locations[3].id | pmh:oai:pubmedcentral.nih.gov:10642371 |
| locations[3].is_oa | True |
| locations[3].source.id | https://openalex.org/S2764455111 |
| locations[3].source.issn | |
| locations[3].source.type | repository |
| locations[3].source.is_oa | False |
| locations[3].source.issn_l | |
| locations[3].source.is_core | False |
| locations[3].source.is_in_doaj | False |
| locations[3].source.display_name | PubMed Central |
| locations[3].source.host_organization | https://openalex.org/I1299303238 |
| locations[3].source.host_organization_name | National Institutes of Health |
| locations[3].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[3].license | cc-by-nc-nd |
| locations[3].pdf_url | https://pmc.ncbi.nlm.nih.gov/articles/PMC10642371/pdf/nihms-1891940.pdf |
| locations[3].version | submittedVersion |
| locations[3].raw_type | Text |
| locations[3].license_id | https://openalex.org/licenses/cc-by-nc-nd |
| locations[3].is_accepted | False |
| locations[3].is_published | False |
| locations[3].raw_source_name | HIV Med |
| locations[3].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/10642371 |
| indexed_in | crossref |
| authorships[0].author.id | https://openalex.org/A5012872939 |
| authorships[0].author.orcid | https://orcid.org/0000-0003-4690-784X |
| authorships[0].author.display_name | Alice Lehman |
| authorships[0].countries | US |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I130238516 |
| authorships[0].affiliations[0].raw_affiliation_string | Division of Infectious Diseases and International Medicine, University of Minnesota, Minneapolis, Minnesota, USA |
| authorships[0].institutions[0].id | https://openalex.org/I130238516 |
| authorships[0].institutions[0].ror | https://ror.org/017zqws13 |
| authorships[0].institutions[0].type | education |
| authorships[0].institutions[0].lineage | https://openalex.org/I130238516 |
| authorships[0].institutions[0].country_code | US |
| authorships[0].institutions[0].display_name | University of Minnesota |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Alice Lehman |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Division of Infectious Diseases and International Medicine, University of Minnesota, Minneapolis, Minnesota, USA |
| authorships[1].author.id | https://openalex.org/A5042319485 |
| authorships[1].author.orcid | https://orcid.org/0000-0002-7009-9144 |
| authorships[1].author.display_name | Jayne Ellis |
| authorships[1].countries | GB |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I4210089966 |
| authorships[1].affiliations[0].raw_affiliation_string | London School of Hygiene and Tropical Medicine, London, UK |
| authorships[1].institutions[0].id | https://openalex.org/I4210089966 |
| authorships[1].institutions[0].ror | https://ror.org/00a0jsq62 |
| authorships[1].institutions[0].type | education |
| authorships[1].institutions[0].lineage | https://openalex.org/I124357947, https://openalex.org/I4210089966 |
| authorships[1].institutions[0].country_code | GB |
| authorships[1].institutions[0].display_name | London School of Hygiene & Tropical Medicine |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Jayne Ellis |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | London School of Hygiene and Tropical Medicine, London, UK |
| authorships[2].author.id | https://openalex.org/A5007837846 |
| authorships[2].author.orcid | |
| authorships[2].author.display_name | Elizabeth Nalintya |
| authorships[2].countries | UG |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I72227227 |
| authorships[2].affiliations[0].raw_affiliation_string | Infectious Disease Institute, Makerere University, Kampala, Uganda |
| authorships[2].institutions[0].id | https://openalex.org/I72227227 |
| authorships[2].institutions[0].ror | https://ror.org/03dmz0111 |
| authorships[2].institutions[0].type | education |
| authorships[2].institutions[0].lineage | https://openalex.org/I72227227 |
| authorships[2].institutions[0].country_code | UG |
| authorships[2].institutions[0].display_name | Makerere University |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Elizabeth Nalintya |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Infectious Disease Institute, Makerere University, Kampala, Uganda |
| authorships[3].author.id | https://openalex.org/A5054093696 |
| authorships[3].author.orcid | https://orcid.org/0000-0002-9431-8938 |
| authorships[3].author.display_name | Nathan C. Bahr |
| authorships[3].countries | US |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I146416000 |
| authorships[3].affiliations[0].raw_affiliation_string | Division of Infectious Diseases, University of Kansas, Kansas City, Kansas, USA |
| authorships[3].institutions[0].id | https://openalex.org/I146416000 |
| authorships[3].institutions[0].ror | https://ror.org/001tmjg57 |
| authorships[3].institutions[0].type | education |
| authorships[3].institutions[0].lineage | https://openalex.org/I146416000 |
| authorships[3].institutions[0].country_code | US |
| authorships[3].institutions[0].display_name | University of Kansas |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Nathan C. Bahr |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Division of Infectious Diseases, University of Kansas, Kansas City, Kansas, USA |
| authorships[4].author.id | https://openalex.org/A5049351239 |
| authorships[4].author.orcid | https://orcid.org/0000-0001-7853-1344 |
| authorships[4].author.display_name | Angela Loyse |
| authorships[4].countries | GB |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I165862685 |
| authorships[4].affiliations[0].raw_affiliation_string | Division of Infection and Immunity Research Institute, St George's University of London, London, UK |
| authorships[4].institutions[0].id | https://openalex.org/I165862685 |
| authorships[4].institutions[0].ror | https://ror.org/040f08y74 |
| authorships[4].institutions[0].type | education |
| authorships[4].institutions[0].lineage | https://openalex.org/I124357947, https://openalex.org/I165862685 |
| authorships[4].institutions[0].country_code | GB |
| authorships[4].institutions[0].display_name | St George's, University of London |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Angela Loyse |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Division of Infection and Immunity Research Institute, St George's University of London, London, UK |
| authorships[5].author.id | https://openalex.org/A5079155294 |
| authorships[5].author.orcid | https://orcid.org/0000-0001-5531-0231 |
| authorships[5].author.display_name | Radha Rajasingham |
| authorships[5].countries | US |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I130238516 |
| authorships[5].affiliations[0].raw_affiliation_string | Division of Infectious Diseases and International Medicine, University of Minnesota, Minneapolis, Minnesota, USA |
| authorships[5].institutions[0].id | https://openalex.org/I130238516 |
| authorships[5].institutions[0].ror | https://ror.org/017zqws13 |
| authorships[5].institutions[0].type | education |
| authorships[5].institutions[0].lineage | https://openalex.org/I130238516 |
| authorships[5].institutions[0].country_code | US |
| authorships[5].institutions[0].display_name | University of Minnesota |
| authorships[5].author_position | last |
| authorships[5].raw_author_name | Radha Rajasingham |
| authorships[5].is_corresponding | True |
| authorships[5].raw_affiliation_strings | Division of Infectious Diseases and International Medicine, University of Minnesota, Minneapolis, Minnesota, USA |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/hiv.13487 |
| open_access.oa_status | hybrid |
| open_access.any_repository_has_fulltext | False |
| created_date | 2023-04-12T00:00:00 |
| display_name | Advanced |
| has_fulltext | True |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T12369 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9998000264167786 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2713 |
| primary_topic.subfield.display_name | Epidemiology |
| primary_topic.display_name | Pneumocystis jirovecii pneumonia detection and treatment |
| related_works | https://openalex.org/W2899084033, https://openalex.org/W2748952813, https://openalex.org/W3031052312, https://openalex.org/W4389568370, https://openalex.org/W3032375762, https://openalex.org/W1995515455, https://openalex.org/W2080531066, https://openalex.org/W3108674512, https://openalex.org/W1506200166, https://openalex.org/W1489783725 |
| cited_by_count | 24 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 16 |
| counts_by_year[1].year | 2024 |
| counts_by_year[1].cited_by_count | 6 |
| counts_by_year[2].year | 2023 |
| counts_by_year[2].cited_by_count | 2 |
| locations_count | 4 |
| best_oa_location.id | doi:10.1111/hiv.13487 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S56736983 |
| best_oa_location.source.issn | 1464-2662, 1468-1293 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | 1464-2662 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | HIV Medicine |
| best_oa_location.source.host_organization | https://openalex.org/P4310320595 |
| best_oa_location.source.host_organization_name | Wiley |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310320595 |
| best_oa_location.license | cc-by-nc-nd |
| best_oa_location.pdf_url | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/hiv.13487 |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by-nc-nd |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | HIV Medicine |
| best_oa_location.landing_page_url | https://doi.org/10.1111/hiv.13487 |
| primary_location.id | doi:10.1111/hiv.13487 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S56736983 |
| primary_location.source.issn | 1464-2662, 1468-1293 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | 1464-2662 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | HIV Medicine |
| primary_location.source.host_organization | https://openalex.org/P4310320595 |
| primary_location.source.host_organization_name | Wiley |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320595 |
| primary_location.license | cc-by-nc-nd |
| primary_location.pdf_url | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/hiv.13487 |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by-nc-nd |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | HIV Medicine |
| primary_location.landing_page_url | https://doi.org/10.1111/hiv.13487 |
| publication_date | 2023-04-11 |
| publication_year | 2023 |
| referenced_works | https://openalex.org/W2792712672, https://openalex.org/W4321153094, https://openalex.org/W2981900703, https://openalex.org/W3045076056, https://openalex.org/W2737438099, https://openalex.org/W2034630867, https://openalex.org/W4214906168, https://openalex.org/W4309648347, https://openalex.org/W3190098602, https://openalex.org/W3175502324, https://openalex.org/W2883578784, https://openalex.org/W2237953232, https://openalex.org/W3042205679, https://openalex.org/W2803792821, https://openalex.org/W2019282465, https://openalex.org/W3014494228, https://openalex.org/W4295038058, https://openalex.org/W3003591415, https://openalex.org/W2922197242, https://openalex.org/W2200954247, https://openalex.org/W3087646693, https://openalex.org/W3211873978, https://openalex.org/W3013209169, https://openalex.org/W4281737454, https://openalex.org/W2905531234, https://openalex.org/W3118286486, https://openalex.org/W3184464075, https://openalex.org/W2991077010, https://openalex.org/W2885819281, https://openalex.org/W4281757796, https://openalex.org/W3143817889, https://openalex.org/W3199962130, https://openalex.org/W3036946849, https://openalex.org/W2921307586, https://openalex.org/W4252970070, https://openalex.org/W4293509742, https://openalex.org/W2127250507, https://openalex.org/W2894217797, https://openalex.org/W3081110493, https://openalex.org/W3031372498, https://openalex.org/W2184980221, https://openalex.org/W2790982980, https://openalex.org/W2899686258, https://openalex.org/W2763181211, https://openalex.org/W3005239418, https://openalex.org/W4307427392, https://openalex.org/W2888696104, https://openalex.org/W3084283850, https://openalex.org/W3140105143, https://openalex.org/W2396820016, https://openalex.org/W3085934795, https://openalex.org/W2967994815, https://openalex.org/W3133728962, https://openalex.org/W3202959270, https://openalex.org/W3198824481, https://openalex.org/W2112956661, https://openalex.org/W2040196644, https://openalex.org/W2493306721, https://openalex.org/W2091056315, https://openalex.org/W3035776038, https://openalex.org/W2922176226, https://openalex.org/W2097732601, https://openalex.org/W1500525462, https://openalex.org/W3032959768, https://openalex.org/W2153415818, https://openalex.org/W2090839261, https://openalex.org/W4212897900, https://openalex.org/W2178328492, https://openalex.org/W2883699015, https://openalex.org/W2911798461, https://openalex.org/W2978206651, https://openalex.org/W2156752460, https://openalex.org/W2016927849, https://openalex.org/W3045373257, https://openalex.org/W3159951247, https://openalex.org/W3098402824, https://openalex.org/W3168494899, https://openalex.org/W2953451547, https://openalex.org/W1920771564, https://openalex.org/W2466552555, https://openalex.org/W3111375365, https://openalex.org/W2148232746, https://openalex.org/W2141425489, https://openalex.org/W2740023892, https://openalex.org/W4226014051, https://openalex.org/W4246197958, https://openalex.org/W4226463333, https://openalex.org/W4223573815, https://openalex.org/W4205869435, https://openalex.org/W4229010266, https://openalex.org/W3009705041, https://openalex.org/W4220744508, https://openalex.org/W3170103830 |
| referenced_works_count | 93 |
| abstract_inverted_index.a | 88, 296 |
| abstract_inverted_index.In | 75, 102 |
| abstract_inverted_index.OI | 139 |
| abstract_inverted_index.TB | 229 |
| abstract_inverted_index.We | 148, 159, 178 |
| abstract_inverted_index.as | 401 |
| abstract_inverted_index.at | 35, 67 |
| abstract_inverted_index.by | 350 |
| abstract_inverted_index.in | 54, 200, 284, 322, 344, 353, 367, 404 |
| abstract_inverted_index.is | 119, 126, 196, 209, 332 |
| abstract_inverted_index.of | 12, 22, 40, 60, 84, 91, 97, 123, 212, 281, 299, 316, 325, 336 |
| abstract_inverted_index.on | 164 |
| abstract_inverted_index.or | 328 |
| abstract_inverted_index.to | 5, 47, 127, 202, 244, 276, 302, 312, 384 |
| abstract_inverted_index.AHD | 43, 65, 85, 310, 372 |
| abstract_inverted_index.ART | 49, 105 |
| abstract_inverted_index.CD4 | 194, 215, 330 |
| abstract_inverted_index.HIV | 25, 30, 55, 292, 342, 402 |
| abstract_inverted_index.POC | 193, 228, 259, 327, 337, 388 |
| abstract_inverted_index.PWH | 300 |
| abstract_inverted_index.The | 121 |
| abstract_inverted_index.WHO | 78, 151 |
| abstract_inverted_index.and | 9, 51, 73, 95, 115, 133, 141, 166, 184, 222, 250, 268, 294, 319, 346, 356, 359, 376, 394 |
| abstract_inverted_index.are | 57, 66, 111, 231, 242, 251, 261, 273, 382 |
| abstract_inverted_index.can | 137, 390 |
| abstract_inverted_index.for | 70, 81, 93, 143, 153, 155, 174, 254, 264 |
| abstract_inverted_index.has | 217 |
| abstract_inverted_index.key | 182 |
| abstract_inverted_index.out | 199 |
| abstract_inverted_index.the | 10, 13, 20, 77, 82, 103, 116, 150, 161, 181, 213, 278, 285, 314, 323 |
| abstract_inverted_index.30%. | 37 |
| abstract_inverted_index.AHD, | 206 |
| abstract_inverted_index.AHD. | 61, 146, 158, 177, 305 |
| abstract_inverted_index.also | 179 |
| abstract_inverted_index.been | 218 |
| abstract_inverted_index.care | 56, 92, 303, 345 |
| abstract_inverted_index.gaps | 186 |
| abstract_inverted_index.have | 107, 373 |
| abstract_inverted_index.high | 68 |
| abstract_inverted_index.many | 234 |
| abstract_inverted_index.risk | 69 |
| abstract_inverted_index.such | 400 |
| abstract_inverted_index.test | 223 |
| abstract_inverted_index.that | 86, 136 |
| abstract_inverted_index.this | 124, 207 |
| abstract_inverted_index.with | 24, 28, 42, 64, 145, 157, 170, 176, 188, 205, 235, 291, 304, 309, 362, 371 |
| abstract_inverted_index.(AHD) | 32 |
| abstract_inverted_index.(ART) | 8 |
| abstract_inverted_index.(POC) | 131 |
| abstract_inverted_index.(PWH) | 26 |
| abstract_inverted_index.(WHO) | 17 |
| abstract_inverted_index.2017, | 76 |
| abstract_inverted_index.Fifty | 38 |
| abstract_inverted_index.While | 192, 257 |
| abstract_inverted_index.World | 14 |
| abstract_inverted_index.alone | 208 |
| abstract_inverted_index.along | 169 |
| abstract_inverted_index.being | 197, 232, 262 |
| abstract_inverted_index.care. | 48, 287, 405 |
| abstract_inverted_index.carry | 313 |
| abstract_inverted_index.could | 340 |
| abstract_inverted_index.given | 220 |
| abstract_inverted_index.major | 58, 98 |
| abstract_inverted_index.novel | 129, 258 |
| abstract_inverted_index.order | 201 |
| abstract_inverted_index.prior | 45 |
| abstract_inverted_index.rapid | 246 |
| abstract_inverted_index.tests | 241, 283 |
| abstract_inverted_index.these | 240, 282, 307, 387 |
| abstract_inverted_index.(OIs). | 101 |
| abstract_inverted_index.Health | 15 |
| abstract_inverted_index.People | 62 |
| abstract_inverted_index.Though | 238 |
| abstract_inverted_index.access | 4 |
| abstract_inverted_index.burden | 315 |
| abstract_inverted_index.causes | 59 |
| abstract_inverted_index.death. | 74 |
| abstract_inverted_index.delays | 352 |
| abstract_inverted_index.hours) | 249 |
| abstract_inverted_index.living | 63 |
| abstract_inverted_index.needed | 275, 383 |
| abstract_inverted_index.people | 23, 370 |
| abstract_inverted_index.reduce | 348 |
| abstract_inverted_index.report | 44 |
| abstract_inverted_index.review | 125 |
| abstract_inverted_index.rolled | 198 |
| abstract_inverted_index.timely | 363, 392 |
| abstract_inverted_index.trials | 381 |
| abstract_inverted_index.(within | 248 |
| abstract_inverted_index.Despite | 2, 289 |
| abstract_inverted_index.Methods | 147 |
| abstract_inverted_index.Results | 191 |
| abstract_inverted_index.benefit | 280 |
| abstract_inverted_index.current | 165 |
| abstract_inverted_index.disease | 31 |
| abstract_inverted_index.failure | 50 |
| abstract_inverted_index.improve | 341 |
| abstract_inverted_index.issues. | 225 |
| abstract_inverted_index.limited | 236 |
| abstract_inverted_index.needed. | 334 |
| abstract_inverted_index.package | 90 |
| abstract_inverted_index.percent | 39 |
| abstract_inverted_index.persons | 41, 144, 156, 175, 204, 308 |
| abstract_inverted_index.present | 301 |
| abstract_inverted_index.provide | 245 |
| abstract_inverted_index.remains | 33 |
| abstract_inverted_index.results | 247 |
| abstract_inverted_index.rollout | 11 |
| abstract_inverted_index.routine | 286 |
| abstract_inverted_index.science | 271 |
| abstract_inverted_index.studies | 272 |
| abstract_inverted_index.testing | 195, 355 |
| abstract_inverted_index.therapy | 7, 113 |
| abstract_inverted_index.thereby | 347, 396 |
| abstract_inverted_index.whether | 386 |
| abstract_inverted_index.workers | 361 |
| abstract_inverted_index.Abstract | 0 |
| abstract_inverted_index.However, | 366 |
| abstract_inverted_index.Numerous | 226 |
| abstract_inverted_index.Visitect | 214 |
| abstract_inverted_index.advanced | 29 |
| abstract_inverted_index.clinical | 279, 380, 398 |
| abstract_inverted_index.continue | 311 |
| abstract_inverted_index.designed | 243 |
| abstract_inverted_index.emerging | 167, 171 |
| abstract_inverted_index.evolved: | 108 |
| abstract_inverted_index.expanded | 3 |
| abstract_inverted_index.identify | 203 |
| abstract_inverted_index.included | 87 |
| abstract_inverted_index.interim, | 104 |
| abstract_inverted_index.multiple | 374 |
| abstract_inverted_index.outcomes | 399 |
| abstract_inverted_index.patients | 358 |
| abstract_inverted_index.platform | 216 |
| abstract_inverted_index.progress | 290 |
| abstract_inverted_index.regimens | 106 |
| abstract_inverted_index.research | 183 |
| abstract_inverted_index.results. | 365 |
| abstract_inverted_index.reviewed | 149 |
| abstract_inverted_index.together | 187 |
| abstract_inverted_index.urgently | 274, 333 |
| abstract_inverted_index.20%–30% | 298 |
| abstract_inverted_index.Pragmatic | 379 |
| abstract_inverted_index.developed | 263 |
| abstract_inverted_index.diagnosis | 393 |
| abstract_inverted_index.evolving. | 120 |
| abstract_inverted_index.globally, | 114 |
| abstract_inverted_index.highlight | 128, 180 |
| abstract_inverted_index.imperfect | 377 |
| abstract_inverted_index.improving | 397 |
| abstract_inverted_index.integrase | 109 |
| abstract_inverted_index.landscape | 118 |
| abstract_inverted_index.morbidity | 318 |
| abstract_inverted_index.mortality | 349 |
| abstract_inverted_index.objective | 122 |
| abstract_inverted_index.platforms | 331 |
| abstract_inverted_index.potential | 189 |
| abstract_inverted_index.providing | 357 |
| abstract_inverted_index.published | 79 |
| abstract_inverted_index.retention | 53, 343, 403 |
| abstract_inverted_index.screening | 94, 140 |
| abstract_inverted_index.settings. | 256 |
| abstract_inverted_index.strategy, | 19 |
| abstract_inverted_index.treatment | 134, 172, 293 |
| abstract_inverted_index.unchanged | 34 |
| abstract_inverted_index.Background | 1 |
| abstract_inverted_index.Investment | 321 |
| abstract_inverted_index.additional | 326 |
| abstract_inverted_index.affordable | 253 |
| abstract_inverted_index.diagnostic | 117 |
| abstract_inverted_index.engagement | 46 |
| abstract_inverted_index.evaluated, | 233 |
| abstract_inverted_index.facilitate | 138, 391 |
| abstract_inverted_index.guidelines | 80, 152 |
| abstract_inverted_index.healthcare | 360 |
| abstract_inverted_index.imperfect, | 239 |
| abstract_inverted_index.infection, | 266 |
| abstract_inverted_index.infections | 72, 100 |
| abstract_inverted_index.inhibitors | 110 |
| abstract_inverted_index.laboratory | 354 |
| abstract_inverted_index.literature | 163 |
| abstract_inverted_index.management | 83 |
| abstract_inverted_index.mortality. | 320 |
| abstract_inverted_index.overcoming | 351 |
| abstract_inverted_index.persistent | 297 |
| abstract_inverted_index.presenting | 27 |
| abstract_inverted_index.proportion | 21 |
| abstract_inverted_index.relatively | 252 |
| abstract_inverted_index.same‐day | 364 |
| abstract_inverted_index.scenarios, | 369 |
| abstract_inverted_index.scientific | 162 |
| abstract_inverted_index.solutions. | 190 |
| abstract_inverted_index.strategies | 135, 173 |
| abstract_inverted_index.summarized | 160 |
| abstract_inverted_index.treatment, | 395 |
| abstract_inverted_index.understand | 277, 385 |
| abstract_inverted_index.Conclusions | 288 |
| abstract_inverted_index.challenging | 219 |
| abstract_inverted_index.development | 324 |
| abstract_inverted_index.diagnostics | 132, 230, 260, 338, 389 |
| abstract_inverted_index.operational | 221 |
| abstract_inverted_index.prevention, | 295 |
| abstract_inverted_index.prophylaxis | 96, 142 |
| abstract_inverted_index.cryptococcal | 265 |
| abstract_inverted_index.diagnostics, | 168 |
| abstract_inverted_index.first‐line | 112 |
| abstract_inverted_index.follow‐up. | 378 |
| abstract_inverted_index.insufficient | 52 |
| abstract_inverted_index.non‐sputum | 227 |
| abstract_inverted_index.real‐world | 368 |
| abstract_inverted_index.sensitivity. | 237 |
| abstract_inverted_index.HIV‐related | 317 |
| abstract_inverted_index.approximately | 36 |
| abstract_inverted_index.comorbidities | 375 |
| abstract_inverted_index.comprehensive | 89 |
| abstract_inverted_index.insufficient; | 210 |
| abstract_inverted_index.opportunistic | 71, 99 |
| abstract_inverted_index.theoretically | 339 |
| abstract_inverted_index.Implementation | 335 |
| abstract_inverted_index.Organization's | 16 |
| abstract_inverted_index.Unfortunately, | 306 |
| abstract_inverted_index.antiretroviral | 6 |
| abstract_inverted_index.histoplasmosis | 267 |
| abstract_inverted_index.implementation | 185, 211, 270 |
| abstract_inverted_index.interpretation | 224 |
| abstract_inverted_index.near‐bedside | 329 |
| abstract_inverted_index.talaromycosis, | 269 |
| abstract_inverted_index.recommendations | 154 |
| abstract_inverted_index.resource‐poor | 255 |
| abstract_inverted_index.point‐of‐care | 130 |
| abstract_inverted_index.‘test‐and‐treat’ | 18 |
| cited_by_percentile_year.max | 100 |
| cited_by_percentile_year.min | 94 |
| corresponding_author_ids | https://openalex.org/A5079155294 |
| countries_distinct_count | 3 |
| institutions_distinct_count | 6 |
| corresponding_institution_ids | https://openalex.org/I130238516 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/1 |
| sustainable_development_goals[0].score | 0.47999998927116394 |
| sustainable_development_goals[0].display_name | No poverty |
| citation_normalized_percentile.value | 0.97085704 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | True |